TRINITY BIOTECH PLC (TRIB) Gross margin 2015–2024
TRINITY BIOTECH PLC (TRIB) gross margin by fiscal year — reported gross profit divided by reported revenue.
34.8%FY2024 · since FY2015: 46.4% → 34.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 34.8% | +0.6 pp |
| FY2023 | 34.2% | +6.6 pp |
| FY2022 | 27.6% | -13.6 pp |
| FY2021 | 41.2% | -6.4 pp |
| FY2020 | 47.6% | +5.5 pp |
| FY2019 | 42.2% | -0.6 pp |
| FY2018 | 42.7% | +0.5 pp |
| FY2017 | 42.3% | -1.4 pp |
| FY2016 | 43.7% | -2.8 pp |
| FY2015 | 46.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice